Defect in efferocytosis leads to alternative activation of macrophages in Francisella infections

Immunology and Cell Biology

Volumn 89, Issue 2, 2011, Pages 167-172

  Mares, Chris A ^a   Sharma, Jyotika ^b   Li, Qun ^b   Rangel, Edward L ^b   Morris, Elizabeth G ^b   Enriquez, Melissa I ^b   Teale, Judy M ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

alternatively activated macrophages; efferocytosis; tularemia

Indexed keywords

ARGINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EFFEROCYTOSIS; ENZYME SYNTHESIS; FRANCISELLA; FRANCISELLA NOVICIDA; IN VIVO STUDY; LUNG INFECTION; MACROPHAGE ACTIVATION; MEMBRANE BIOLOGY; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION;

ANIMALS; ARGINASE; BIOLOGICAL MARKERS; FRANCISELLA; GRAM-NEGATIVE BACTERIAL INFECTIONS; LUNG; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MODELS, IMMUNOLOGICAL; NECROSIS; PHAGOCYTOSIS; UP-REGULATION;

FRANCISELLA;

EID: 79951945330     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.81     Document Type: Article

References (22)

1. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-686. (Pubitemid 39457982)
2. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 2009; 27: 451-483.
3. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-969.
4. Elkins KL, Cowley SC, Bosio CM. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect 2003; 5: 135-142.
5. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA et al. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 2008; 76: 5843-5852.
6. Mares CA, Ojeda SS, Morris EG, Li Q, Teale JM. Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect Immun 2008; 76: 3001-3010.
7. Sharma J, Li Q, Mishra BB, Pena C, Teale JM. Lethal pulmonary infection with Francisella novicida is associated with severe sepsis. J Leukoc Biol 2009; 86: 491-504.
8. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005; 17: 359-365. (Pubitemid 40848537)
9. Qin S, Wang H, Yuan R, Li H, Ochani M, Ochani K et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006; 203: 1637-1642. (Pubitemid 44036267)
10. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289. (Pubitemid 351432799)
11. Benoit M, Ghigo E, Capo C, Raoult D, Mege JL. The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization: a model for Q fever endocarditis. PLoS Pathog 2008; 4: e1000066.
12. Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol 2008; 214: 161-178. (Pubitemid 351160154)
13. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 2009; 5: e1000371.
14. Lai XH, Golovliov I, Sjostedt A. Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect Immun 2001; 69: 4691-4694. (Pubitemid 32574475)
15. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-1221. (Pubitemid 39540438)
16. Wang H, Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008; 26: 711-715. (Pubitemid 351905818)
17. Kahnert A, Seiler P, Stein M, Bandermann S, Hahnke K, Mollenkopf H et al. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur J Immunol 2006; 36: 631-647.
18. Shirey KA, Cole LE, Keegan AD, Vogel SN. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J Immunol 2008; 181: 4159-4167.
19. Butchar JP, Cremer TJ, Clay CD, Gavrilin MA, Wewers MD, Marsh CB et al. Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS One 2008; 3: e2924.
20. Bottcher A, Gaipl US, Furnrohr BG, Herrmann M, Girkontaite I, Kalden JR et al. Involvement of phosphatidylserine, alphavbeta3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis Rheum 2006; 54: 927-938.
21. Krysko DV, D'Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 2006; 11: 1709-1726. (Pubitemid 44371047)
22. Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2009; 2: re3.